These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29933112)

  • 1. BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages.
    Wang K; Li S; Gao Y; Feng X; Liu W; Luo R; Song Y; Ji Tu ; Liu Y; Yang C
    Bone; 2018 Sep; 114():257-267. PubMed ID: 29933112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
    Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
    J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
    Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
    Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin E3 ligase Itch negatively regulates osteoclast formation by promoting deubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.
    Zhang H; Wu C; Matesic LE; Li X; Wang Z; Boyce BF; Xing L
    J Biol Chem; 2013 Aug; 288(31):22359-68. PubMed ID: 23782702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
    Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
    J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
    Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl terminus of Hsp70-interacting protein regulation of osteoclast formation in mice through promotion of tumor necrosis factor receptor-associated factor 6 protein degradation.
    Li S; Shu B; Zhang Y; Li J; Guo J; Wang Y; Ren F; Xiao G; Chang Z; Chen D
    Arthritis Rheumatol; 2014 Jul; 66(7):1854-63. PubMed ID: 24578159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Cbl negatively regulates TRAF6-mediated NF-
    Jang HD; Hwang HZ; Kim HS; Lee SY
    Cell Mol Biol Lett; 2019; 24():29. PubMed ID: 31123462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts.
    Bai S; Zha J; Zhao H; Ross FP; Teitelbaum SL
    J Biol Chem; 2008 Nov; 283(45):30861-7. PubMed ID: 18768464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M; Suzuki R; Shirataki Y; Sakagami H; Tamura N; Tomomura A
    PLoS One; 2015; 10(6):e0130174. PubMed ID: 26083531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
    Lin J; Lee D; Choi Y; Lee SY
    Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
    Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
    J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6.
    Shin JN; Kim I; Lee JS; Koh GY; Lee ZH; Kim HH
    J Biol Chem; 2002 Mar; 277(10):8346-53. PubMed ID: 11751921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.
    Maruyama K; Kawagoe T; Kondo T; Akira S; Takeuchi O
    J Biol Chem; 2012 Aug; 287(34):29114-24. PubMed ID: 22773835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis.
    Wu DJ; Gu R; Sarin R; Zavodovskaya R; Chen CP; Christiansen BA; Zarbalis KS; Adamopoulos IE
    J Autoimmun; 2016 Sep; 73():73-84. PubMed ID: 27330028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.